SCHEMBL176262

SCHEMBL176262

CCc1cc(NS(=O)(=O)c2ccc(NC(=O)NCc3cccnc3)cc2)ccc1OC

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 20/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL166349 0.92 NAMPT (1.00) NAMPT
SCHEMBL29635789 0.90 NAMPT (0.86) NAMPT
SCHEMBL165042 0.90 NAMPT (0.86) NAMPT
SCHEMBL29635774 0.89 NAMPT (0.84) NAMPT
SCHEMBL165860 0.89 NAMPT (0.84) NAMPT
SCHEMBL164813 0.89 NAMPT (0.84) NAMPT
SCHEMBL167672 0.88 NAMPT (1.00) NAMPT
SCHEMBL29635637 0.88 NAMPT (1.00) NAMPT
SCHEMBL29635805 0.87 NAMPT (0.84) NAMPT
SCHEMBL166816 0.87 NAMPT (0.84) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611777-A1 4- { [ ( PYRIDIN- 3 - YL -METHYL) AMINOCARBONYL]AMINO} BENZENE - SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER Forma TM, LLC. (US) 2013-07-10 EP disclosed
WO-2012031196-A1 4- { [ ( PYRIDIN- 3 - YL -METHYL) AMINOCARBONYL] AMINO} BENZENE - SULFONE DERIVATIVES AS NAMPT INHIBITORS FOR THERAPY OF DISEASES SUCH AS CANCER FORMA THERAPEUTICS, INC. (US) 2012-03-08 WO disclosed